Novel drug delivery system produced by centrifugal technologies – composed to minimize adverse immune reactions and designed for optimised therapeutic effects

Informazioni relative al progetto

DECENT AID

ID dell’accordo di sovvenzione: 324275

Progetto concluso

Data di avvio 1 Aprile 2013

Data di completamento 31 Marzo 2017

Finanziato da

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Costo totale € 1 492 545,10

Contributo UE € 1 492 545,10

Coordinato da

ABNOBA GMBH
Germany